Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
This gene (ENSG00000233933) corresponds to a pseudogene related to the non-metastatic cells 2, protein (a nucleoside diphosphate kinase) family. Pseudogenes are genetically similar to protein-coding genes but are rendered nonfunctional by disabling mutations and are not translated into proteins[3][4]. Recent research shows some pseudogenes are transcribed and can regulate other genes via RNA-based mechanisms, but the vast majority—including this one—have no well-defined biological or therapeutic role and are not regarded as valid drug targets. The use of "protein expressed in pseudogene" is non-standard; typically, the parent gene should be specified for clarity[1][4]. Key Context: - Pseudogenes are "molecular corpses"—segments of DNA resembling protein-coding genes but lacking coding potential due to disabling mutations[3]. - Rarely, some pseudogenes are transcribed and give rise to regulatory non-coding RNAs, but these are exceptions[1][4]. - Although studied for potential regulatory or biomarker roles, especially in cancer, ENSEMBL gene ENSG00000233933 and its described function as "non-metastatic cells 2, protein expressed in pseudogene" do not meet criteria as a drug target, receptor, or biomarker in clinical or research use[1][4]. Note: If you need structured information about active protein-coding targets, a different gene or protein should be specified. This entry is likely incorrect for therapeutic targeting purposes.
Null
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Non-metastatic cells 2, protein expressed (pseudogene) (Null).